Literature DB >> 17899868

Regional estimates of breast cancer burden in Italy.

Enrico Grande1, Riccardo Inghelmann, Silvia Francisci, Arduino Verdecchia, Andrea Micheli, Paolo Baili, Riccardo Capocaccia, Roberta De Angelis.   

Abstract

AIMS AND
BACKGROUND: Breast cancer is the most common cancer and the leading cause of cancer death among women. Knowledge of the present and future burden of the disease at a regional and national scale is a major issue in Italy, where the frequency and coverage of screening programs vary considerably across the country. This study presents estimates and projections of the female breast cancer incidence, prevalence and mortality for Italy and all Italian regions in the period 1970-2010.
METHODS: The estimates were obtained by applying the MIAMOD method, a statistical back-calculation approach to derive incidence and prevalence figures from mortality and relative survival data. Published data from the Italian cancer registries were modelled to obtain regional and national estimates of breast cancer survival.
RESULTS: Breast cancer mortality has been declining from the late 1980s in the northern-central regions and from the mid 1990s in the southern regions Puglia, Sicilia and Sardegna. Stable mortality rates are estimated for the other southern regions in the 2000's first decade. The incidence rate in Italy is estimated as increasing until the late 1990s, and stable thereafter (93 per 100,000). The incidence curve is also estimated to flatten in many northern-central regions from the late 1990s or later. Rising incidence trends are estimated in all southern regions, with the exception of Puglia. About 8,500 deaths, 37,000 new diagnoses and 416,000 prevalent cases for breast cancer are estimated among Italian women in 2005. In the same year, the proportion of prevalent cases in the northern area (1221 per 100,000) is about twice that estimated in the South (685 per 100,000). DISCUSSION: The geographical variation in female breast cancer burden can be explained by the unequal distribution of screening. A more widespread screening activity in the southern regions would help to bridge the gap between northern-central and southern regions. Continuous monitoring of regional epidemiological indicators for breast cancer is crucial to evaluate the effect of different health measures taken to control breast cancer in Italy.

Entities:  

Mesh:

Year:  2007        PMID: 17899868     DOI: 10.1177/030089160709300408

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  8 in total

1.  The burden of breast cancer from China to Italy.

Authors:  Alessia Levaggi; Francesca Poggio; Matteo Lambertini
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

2.  Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study.

Authors:  Stefania Gori; Matteo Clavarezza; Salvatore Siena; Jennifer Foglietta; Emiliana Tarenzi; Monica Giordano; Annamaria Molino; Claudio Graiff; Vittorio Fusco; Oscar Alabiso; Editta Baldini; Teresa Gamucci; Giuseppe Altavilla; Davide Dondi; Marco Venturini
Journal:  BMC Cancer       Date:  2012-04-30       Impact factor: 4.430

3.  Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer.

Authors:  Andrea Camerini; Sara Donati; Paolo Viacava; Olimpia Siclari; Cheti Puccetti; Gianna Tartarelli; Chiara Valsuani; Filomena De Luca; Leonardo Martini; Andrea Cavazzana; Domenico Amoroso
Journal:  J Exp Clin Cancer Res       Date:  2011-04-11

4.  Diagnostic and therapeutic path of breast cancer: effectiveness, appropriateness, and costs--results from the DOCMa study.

Authors:  Maria Rosaria Giovagnoli; Adriana Bonifacino; Cosimo Neglia; Marco Benvenuto; Francesco Vincenzo Sambati; Lorenzo Giolli; Alessandra Giovagnoli; Prisco Piscitelli
Journal:  Clin Interv Aging       Date:  2015-04-17       Impact factor: 4.458

5.  Study of Inflammatory and Infection Markers in Periprosthetic Fluid: Correlation with Blood Analysis in Retrospective and Prospective Studies.

Authors:  Andrea Lisa; Cristina Belgiovine; Luca Maione; Andrea Rimondo; Andrea Battistini; Benedetta Agnelli; Matteo Murolo; Leonardo Galtelli; Marta Monari; Marco Klinger; Valeriano Vinci
Journal:  Biomed Res Int       Date:  2021-03-19       Impact factor: 3.411

6.  Survival of Breast Cancer by Stage, Grade and Molecular Groups in Mallorca, Spain.

Authors:  Maria Clara Pascual; Juan José Montaño; Paula Franch; Carmen Sánchez-Contador; Maria Ramos
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

7.  Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005.

Authors:  Prisco Piscitelli; Antonio Santoriello; Franco M Buonaguro; Massimo Di Maio; Giovanni Iolascon; Francesca Gimigliano; Alessandra Marinelli; Alessandro Distante; Giuseppe Serravezza; Emiliano Sordi; Katia Cagossi; Fabrizio Artioli; Michele Santangelo; Alfredo Fucito; Raffaele Gimigliano; Maria Luisa Brandi; Massimo Crespi; Antonio Giordano
Journal:  J Exp Clin Cancer Res       Date:  2009-06-19

8.  An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study.

Authors:  Carlo Lazzaro; Roberto Bordonaro; Francesco Cognetti; Alessandra Fabi; Sabino De Placido; Grazia Arpino; Paolo Marchetti; Andrea Botticelli; Paolo Pronzato; Elisa Martelli
Journal:  Clinicoecon Outcomes Res       Date:  2013-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.